Pharmafoods Q3 FY2026 Analysis: Guidance Points to Strategic Profit Recovery Amid Investment Phase
Pharmafoods (TSE:2929) Q3 FY2026 Analysis: Guidance Points to Strategic Profit Recovery Amid Investment Phase
Pharmafoods (TSE:2929) Q3 FY2026 Analysis: Guidance Points to Strategic Profit Recovery Amid Investment Phase
Rock (TSE:2910) Field Co.,Ltd. FY2026 Analysis: Guidance Points to Margin Recovery Amid Flat Sales
SCAT (TSE:3974) Inc. Q2 FY2026 Analysis: Profitability Outpaces Revenue Growth Amid Structural Shift
Shinto (TSE:2776) Holdings Co., Ltd. Q1 FY2027 Analysis: Resource Trading Drives Strong Turnaround
Shoei (TSE:8079) Foods Corporation Q2 FY2026 Analysis: Strong Profit Growth Signals Margin Strength
Sunrise (TSE:2751) Service Co., Ltd. FY2026 Analysis: Guidance Points to Accelerating Growth Amid Profit Divergence
Top (TSE:7640) Culture Co., Ltd. Q2 FY2026 Analysis: Profitability Rebounds Amid Strategic Retail Focus
Upcon (TSE:5075) Co., Ltd. Q1 FY2027 Analysis: Strong Core Demand Supports High Profitability
Asakuma (TSE:7678) FY2027 Analysis: Guidance Points to Strong Growth Despite Margin Pressure
Beauty Garage (TSE:3180) FY2026 (ended Apr 2026): Revenue +13.3% to JPY 38.2bn, Operating Profit -4.8% to JPY 1.52bn. Next year forecast: Revenue JPY 43.2bn (+13.0%), OP JPY 2.22bn (+46.1%).